| __timestamp | Lantheus Holdings, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 44820000 |
| Thursday, January 1, 2015 | 78634000 | 82080000 |
| Friday, January 1, 2016 | 75374000 | 97130000 |
| Sunday, January 1, 2017 | 92157000 | 121271000 |
| Monday, January 1, 2018 | 93326000 | 153548000 |
| Tuesday, January 1, 2019 | 103132000 | 202541000 |
| Wednesday, January 1, 2020 | 110171000 | 245164000 |
| Friday, January 1, 2021 | 218817000 | 285773000 |
| Saturday, January 1, 2022 | 233827000 | 325998000 |
| Sunday, January 1, 2023 | 267194000 | 332540000 |
Unleashing insights
In the ever-evolving landscape of the healthcare sector, understanding the financial dynamics of key players is crucial. Over the past decade, Lantheus Holdings, Inc. and PTC Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Lantheus Holdings saw a steady increase in SG&A costs, starting at approximately $72 million and peaking at $267 million in 2023, marking a growth of over 270%. Meanwhile, PTC Therapeutics began with $45 million in 2014 and reached $332 million by 2023, reflecting a staggering increase of over 630%. This data highlights the aggressive expansion and operational scaling of PTC Therapeutics compared to Lantheus Holdings. As these companies continue to innovate and expand, monitoring their SG&A expenses provides valuable insights into their strategic priorities and market positioning.
AbbVie Inc. vs Lantheus Holdings, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Opthea Limited
Annual Revenue Comparison: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs ACADIA Pharmaceuticals Inc.
Lantheus Holdings, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Evotec SE